Trial expected to screen more than 1900 early-stage breast cancer patients at 120+ sites in 12 countries across Europe, commencing in Q4 2023 Study will evaluate whether elacestrant can delay occurrence of metastasis or death compared to standard adjuvant endocrine therapy in early-stage…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.